WO2001066800A8 - Human single nucleotide polymorphisms - Google Patents

Human single nucleotide polymorphisms

Info

Publication number
WO2001066800A8
WO2001066800A8 PCT/US2001/007268 US0107268W WO0166800A8 WO 2001066800 A8 WO2001066800 A8 WO 2001066800A8 US 0107268 W US0107268 W US 0107268W WO 0166800 A8 WO0166800 A8 WO 0166800A8
Authority
WO
WIPO (PCT)
Prior art keywords
single nucleotide
nucleotide polymorphisms
human single
nucleic acid
acid segments
Prior art date
Application number
PCT/US2001/007268
Other languages
French (fr)
Other versions
WO2001066800A2 (en
WO2001066800A3 (en
Inventor
Michele Cargill
James S Ireland
Eric S Lander
Original Assignee
Whitehead Biomedical Inst
Michele Cargill
James S Ireland
Eric S Lander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst, Michele Cargill, James S Ireland, Eric S Lander filed Critical Whitehead Biomedical Inst
Priority to AU2001245489A priority Critical patent/AU2001245489A1/en
Publication of WO2001066800A2 publication Critical patent/WO2001066800A2/en
Publication of WO2001066800A8 publication Critical patent/WO2001066800A8/en
Publication of WO2001066800A3 publication Critical patent/WO2001066800A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The invention provides nucleic acid segments of the human genome, particularly nucleic acid segments from genes including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis.
PCT/US2001/007268 2000-03-07 2001-03-07 Human single nucleotide polymorphisms WO2001066800A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001245489A AU2001245489A1 (en) 2000-03-07 2001-03-07 Human single nucleotide polymorphisms

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18751000P 2000-03-07 2000-03-07
US60/187,510 2000-03-07
US20612900P 2000-05-22 2000-05-22
US60/206,129 2000-05-22

Publications (3)

Publication Number Publication Date
WO2001066800A2 WO2001066800A2 (en) 2001-09-13
WO2001066800A8 true WO2001066800A8 (en) 2002-02-14
WO2001066800A3 WO2001066800A3 (en) 2003-06-05

Family

ID=26883100

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/007268 WO2001066800A2 (en) 2000-03-07 2001-03-07 Human single nucleotide polymorphisms

Country Status (3)

Country Link
US (1) US20020032319A1 (en)
AU (1) AU2001245489A1 (en)
WO (1) WO2001066800A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100896A2 (en) * 2001-06-13 2002-12-19 Centre National De La Recherche Scientifique (C.N.R.S.) Method for diagnosing cancer susceptibility
US20040053317A1 (en) * 2002-09-10 2004-03-18 Sidney Kimmel Cancer Center Gene segregation and biological sample classification methods
AU2003299818A1 (en) * 2002-12-20 2004-07-22 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
WO2004104172A2 (en) * 2003-05-15 2004-12-02 Bioarray Solutions, Ltd. Hybridization-mediated analysis of polymorphisms
WO2005049860A2 (en) * 2003-11-05 2005-06-02 Karolinska Innovations Ab Diagnostic and therapeutic methods and assays
HUE025996T2 (en) * 2003-12-01 2016-05-30 Kudos Pharm Ltd DNA damage repair inhibitors for treatment of cancer
US8093004B2 (en) * 2004-04-28 2012-01-10 Council Of Scientific & Industrial Research Method of detecting and predicting bronchodilatory response to beta agonist
DE602005016676D1 (en) * 2004-06-14 2009-10-29 Integragen Sa HUMAN ADIPOSITAS SUSCEPTIBILITY TESTING AND USE THEREOF FOR A VOLTAGE-CONTROLLED KALIUM CHANNEL
US7323308B2 (en) * 2004-09-03 2008-01-29 Affymetrix, Inc. Methods of genetic analysis of E. coli
CN101142321B (en) * 2004-11-18 2012-06-06 耶鲁大学 Methods and compositions for treating ocular disorders
GB2424886A (en) 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
FI20050640A0 (en) * 2005-06-16 2005-06-16 Faron Pharmaceuticals Oy Compounds for treating or preventing diseases or disorders related to amine oxidases
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
WO2007028161A2 (en) * 2005-09-02 2007-03-08 The University Of Toledo Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726905B1 (en) * 1993-11-03 2005-03-23 Orchid BioSciences, Inc. Single nucleotide polymorphisms and their use in genetic analysis
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
US20020032319A1 (en) 2002-03-14
AU2001245489A1 (en) 2001-09-17
WO2001066800A2 (en) 2001-09-13
WO2001066800A3 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
WO1998020165A3 (en) Biallelic markers
Wagner et al. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations
WO2001066800A8 (en) Human single nucleotide polymorphisms
WO2001090419A3 (en) Methods for genetic analysis of dna to detect sequence variances
CA2289872A1 (en) Target-dependent reactions using structure-bridging oligonucleotides
WO2001013086A3 (en) Detection of nucleic acids
CA2190588A1 (en) Pteridine nucleotide analogs as fluorescent dna probes
EP2341058A3 (en) Oligonucleotide Analogues
WO2001077384A3 (en) Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
EP1212449A4 (en) Method for amplifying signal-flanking sequences from unknown genomic dna
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
WO1996006949A3 (en) Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid
WO2003014388A3 (en) Method and nucleic acids for the analysis of colon cancer
DE69816467D1 (en) ROBO: A FAMILY OF POLYPEPTIDES AND NUCLEIC ACIDS EFFECTIVELY IN NERVOUS LINE
WO2001042511A3 (en) Ibd-related polymorphisms
WO2000058519A3 (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
WO2001018250A3 (en) Single nucleotide polymorphisms in genes
ATE427362T1 (en) POLYMORPHOIC MARKERS OF THE LSR GENE
WO2001038576A3 (en) Human single nucleotide polymorphisms
WO2001051659A3 (en) Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders
WO2003054167A3 (en) Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
WO2001029262A3 (en) Genotyping reagents, kits and methods of use thereof
WO1999053095A3 (en) Biallelic markers
CA2348828A1 (en) Genomic and complete cdna sequences of apm1 and biallelic markers thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP